Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,373,200 | $4,801,200 | $4,348,600 | $4,014,900 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Cost of Goods Sold | $3,140,000 | $2,818,400 | $2,595,400 | $2,311,500 |
| Gross Profit | $2,233,200 | $1,982,800 | $1,753,200 | $1,703,400 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $266,500 | $201,700 | $209,000 | $228,500 |
| SG&A Expenses | $266,500 | $258,000 | $209,000 | $228,500 |
| Sales & Mktg Exp. | $0 | $56,300 | $0 | $0 |
| Other Operating Expenses | $1,102,200 | $0 | $914,000 | $815,500 |
| Operating Expenses | $1,368,700 | $258,000 | $1,123,000 | $1,044,000 |
| Operating Income | $864,500 | $1,724,800 | $630,200 | $659,400 |
| % Margin | 16.1% | 35.9% | 14.5% | 16.4% |
| Other Income/Exp. Net | -$114,900 | -$1,117,600 | -$179,400 | -$154,400 |
| Pre-Tax Income | $749,600 | $607,200 | $450,800 | $505,000 |
| Tax Expense | $150,200 | $132,200 | $100,100 | $101,900 |
| Net Income | $455,700 | $352,000 | $271,000 | $412,200 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS | 4.53 | 3.54 | 2.72 | 4.15 |
| % Growth | 28% | 30.1% | -34.5% | – |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| Weighted Avg Shares Out | 99,900 | 99,500 | 99,200 | 99,000 |
| Weighted Avg Shares Out Dil | 102,200 | 101,300 | 100,400 | 100,200 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $137,400 | $143,500 | $175,700 | $164,300 |
| Depreciation & Amortization | $299,600 | $273,900 | $243,600 | $219,600 |
| EBITDA | $1,186,600 | $1,005,700 | $870,100 | $888,900 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |